Spanish doctors decry low Mohs' surgery use
This article was originally published in Clinica
Only 1% of skin cancer operations in Spain are performed using micrographic - or Mohs' - surgery, compared to 35% in the US. So said dermatologists of Madrid's Clinica La Luz, in a campaign launched this week to raise awareness of the technique's effectiveness in averting or treating the more invasive forms of skin cancer.
You may also be interested in...
Novartis’s cancer drug has now been filed for multiple sclerosis in the US, armed with a priority review, and in Europe.
Aetion is also working with the US Food and Drug Administration and a number of biopharma companies on projects involving use of real-world evidence.
Increased fines and penalties are on the cards for manufacturing facilities that fail to comply with proposed new requirements.